Isoplex

Succinylated Gelatin, the active ingredient in Isoplex, is an excipient presented as a sterile isotonic solution for intravenous use. It provides a sterile, isotonic medium that serves as a diluent or carrier for parenteral medications, supporting safe and compatible drug administration.

GNH USA supplies Isoplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product complies with EU GMP standards and is distributed through a regulated supply chain to meet the needs of clinical and commercial settings.

Isoplex is used as an intravenous diluent and carrier for parenteral drug formulations, facilitating safe delivery of various therapeutic agents.

Parenteral chemotherapy: provides an isotonic vehicle that maintains drug stability during infusion. Antibiotic infusion: serves as a compatible diluent for intravenous antibiotics, ensuring appropriate osmolarity. Vaccine reconstitution: acts as a sterile carrier for reconstituted vaccines, supporting accurate dosing.

Succinylated gelatin is generally well tolerated, but infusion of the solution may be associated with certain adverse reactions.

Common Side Effects: - Infusion site erythema: mild redness at the injection site. - Transient hypotension: brief drop in blood pressure during administration. - Mild fever: low‑grade temperature increase post‑infusion. - Nausea: occasional feeling of sickness during infusion.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical intervention. - Hemolysis: destruction of red blood cells in susceptible individuals. - Thromboembolic events: rare clot formation associated with intravenous administration. - Acute renal failure: rare kidney impairment following reaction.

When using Isoplex, several precautions should be observed to ensure patient safety and product integrity. - Assess patient history: verify absence of gelatin or protein allergy before administration. - Monitor infusion site: watch for redness, swelling, or pain during and after infusion. - Use aseptic technique: maintain sterility while preparing and administering the solution. - Compatibility check: confirm chemical compatibility with the intended drug before mixing. - Label correctly: include concentration, batch number, and expiry date on the container. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Succinylated gelatin may interact with certain drugs or solutions, affecting stability or safety.

Major Interactions (Avoid): - Incompatible with high pH solutions: may cause precipitation or loss of efficacy. - Reacts with divalent metal ions (e.g., calcium, magnesium): can lead to gel formation.

Moderate Interactions (Monitor Closely): - May reduce stability of some biologics: monitor potency when mixed. - Potential for altered osmolarity with hypertonic drugs: adjust infusion rates accordingly. - Possible decreased efficacy of certain antibiotics: assess therapeutic levels.